GENIX PHARMACEUTICALS CORP (GENX.CA) Stock Cash Flow
Canada - TSX-V:GENX - CA37232A1093 - Common Stock
0.035 CAD
+0.01 (+16.67%)
| TTM (2025-4-30) | 2024 (2024-10-31) | 2023 (2023-10-31) | 2022 (2022-10-31) | 2021 (2021-10-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -87.40K | -73.20K | -4.40M | -1.07M | -1.65M | |||
| Depreciation Amortization | 1.10K | 1.10K | 547.40K | 564.20K | 536.60K | |||
| Change In Working Capital | 38.50K | 29.80K | 56.20K | -5.70K | -123.80K | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | N/A | 0.00 | 0.00 | 2.10K | N/A | |||
| Other non cash items | -115.90K | -145.10K | 3.57M | 295.90K | 811.40K | |||
| OPERATING CASH FLOW | -163.50K | -187.30K | -220.70K | -219.60K | -428.30K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | 0.00 | -3.30K | 0.00 | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| INVESTING CASH FLOW | N/A | N/A | 0.00 | -3.30K | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 158.40K | 187.20K | 223.00K | 93.40K | -129.50K | |||
| Stock Issued/Repurchased | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | -10.00K | |||
| FINANCING CASH FLOW | 158.40K | 187.20K | 223.00K | 93.40K | -129.50K | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | -5.20K | -100.00 | 2.40K | -129.60K | -557.80K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -163.50K | -187.30K | -220.70K | -219.60K | -428.30K | |||
| Capital Expenditure | N/A | N/A | 0.00 | -3.30K | 0.00 | |||
| FREE CASH FLOW | -163.50K | -187.30K | -220.70K | -222.90K | -428.30K | |||
All data in CAD